Journal of Antimicrobial Chemotherapy (2000) 46, 465-469
© 2000 The British Society for Antimicrobial Chemotherapy
Brief reports |
In vitro activity of an evernimicin derivative, SCH27899, against anaerobic bacteria and Propionibacterium acnes
Institute of Anaerobic Bacteriology, Gifu University School of Medicine, 40 Tsukasa-machi Gifu, 500-8705, Japan
The in vitro activity of SCH27899, a novel oligosaccharide antimicrobial agent, was compared with those of representatives of six classes of antimicrobial agents (piperacillin, clarithromycin, clindamycin, vancomycin, sitafloxacin and metronidazole) against clinical isolates of anaerobic bacteria and Propionibacterium acnes. Against Peptostreptococcus spp. and Clostridium difficile, SCH27899 was the most potent (MIC90 < 0.125 mg/L) of the agents examined. Besides these Gram-positive anaerobes, SCH27899 showed a moderate level of activity against Prevotella bivia, Prevotella intermedia and Porphyromonas spp. (MIC90
4 mg/L).
* Corresponding author. Tel: +81-58-267-2342; Fax: +81-58-265-9001; E-mail: kuni{at}cc.gifu-u.ac.jp